Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6OZS
|
||||
| Drug Name |
(8R,9S,10S,13S,14S,17S)-13-methyl-3-phenyl-10-vinyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
|
||||
| Synonyms |
CHEMBL398840
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H32O
|
||||
| Canonical SMILES |
C[C@]12CC[C@H]3[C@@H](CC=C4C=C(CC[C@]34C=C)c5ccccc5)[C@@H]1CC[C@@H]2O
|
||||
| InChI |
InChI=1S/C26H32O/c1-3-26-16-13-19(18-7-5-4-6-8-18)17-20(26)9-10-21-22-11-12-24(27)25(22,2)15-14-23(21)26/h3-9,17,21-24,27H,1,10-16H2,2H3/t21-,22-,23-,24-,25-,26-/m0/s1
|
||||
| InChIKey |
NUZBYJNMAHLREU-FRSCJGFNSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor beta | Target Info | [1587926] | ||
| mRNA of androgen receptor | Target Info | [1587926] | |||
| Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
| Validated nuclear estrogen receptor beta network | |||||
| Validated nuclear estrogen receptor alpha networksmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | |||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.